Commonwealth Financial Services’s Intellia Therapeutics NTLA Stock Holding History

Commonwealth Financial Services’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$192K	Buy	+11,327	New	+$159K	0.03%	295

Other funds holding NTLA

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

Commonwealth Financial Services's NTLA Position: Q2 2026 in Review

Commonwealth Financial Services opened a new position in Intellia Therapeutics (NTLA) in Q2 2026: 11,327 shares worth $192K. The stake represents 0.03% of the portfolio and ranks #295 among its holdings.

29 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

Commonwealth Financial Services held 11,327 shares of Intellia Therapeutics worth $192K as of Q2 2026.
Intellia Therapeutics was a new Commonwealth Financial Services position in Q2 2026.
Intellia Therapeutics made up 0.03% of Commonwealth Financial Services's portfolio in Q2 2026, its #295 holding.
29 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Commonwealth Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.